SCHEMBL4068824

SCHEMBL4068824

Cc1ccccc1Nc1ccc(N)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 2/20 0.50
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
SLC2A1 P11166 1/20 0.43
CCNA2 P20248 2/20 0.42
CDK2 P24941 2/20 0.42
CCNK O75909 1/20 0.42
CCND3 P30281 1/20 0.42
CDK9 P50750 1/20 0.42
CDK6 Q00534 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
MEN1 O00255 1/20 0.40
GFER P55789 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4070837 0.80 HPGD (0.52) MAPK10HTTSMN1; SMN2NPC1RAB9A
SCHEMBL4667375 0.80 CYP3A4 (0.41) MAPK10SMN1; SMN2PKMMEN1GFER
SCHEMBL14850474 0.79 NPC1 (0.54) MAPK10HTTSMN1; SMN2SLC2A1CCNA2
SCHEMBL3160018 0.79 GRIN2D (0.37) MAPK10RAB9APKMMEN1GFER
SCHEMBL4064502 0.78 RAB9A (0.44) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL10094602 0.77 MAPT (0.45) HTTSMN1; SMN2SLC2A1NPC1RAB9A
SCHEMBL30202244 0.77 FTO (0.46) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL20796132 0.77 FTO (0.46) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL30400745 0.76 NNMT (0.58) LMNAMEN1KMT2A
SCHEMBL3150722 0.76 AURKA (0.48) MEN1KMT2APIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028945-B9 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2009-02-18 EP disclosed
EP-1028945-B1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC (US) 2007-07-11 EP disclosed
US-6458813-B1 2-CYCLOHEXYLOXY-5-(2-CHLOROPHENYLCARBONYLAMINO)PYRIDINE, FOR EXAMPLE; TREATING INFLAMMATION, PAIN, DIABETES, CANCER AMGEN INC. 2002-10-01 US disclosed
US-6333341-B1 TUMOR NECROSIS FACTOR, ANTIINFLAMMATORY AGENTS AND ANALGESICS AMGEN INC. 2001-12-25 US disclosed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 US disclosed
EP-1028945-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS Amgen Inc. (US) 2000-08-23 EP disclosed
WO-1999024404-A1 SUBSTITUTED PYRIDINE COMPOUNDS AS ANTI-INFLAMMATORY AGENTS AMGEN INC. (US) 1999-05-20 WO disclosed